Leerink Partnrs Brokers Reduce Earnings Estimates for INSP

Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) - Investment analysts at Leerink Partnrs dropped their FY2028 EPS estimates for Inspire Medical Systems in a research note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst M. Kratky now expects that the company will post earnings of $5.62 per share for the year, down from their previous estimate of $5.69. The consensus estimate for Inspire Medical Systems' current full-year earnings is $1.33 per share.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its quarterly earnings results on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%.

Several other equities research analysts also recently weighed in on the stock. Morgan Stanley reduced their price objective on shares of Inspire Medical Systems from $230.00 to $220.00 and set an "overweight" rating for the company in a report on Tuesday. Truist Financial dropped their price target on shares of Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating on the stock in a research report on Tuesday. Wells Fargo & Company dropped their price target on shares of Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating on the stock in a research report on Tuesday. Royal Bank of Canada reiterated an "outperform" rating and issued a $260.00 price target on shares of Inspire Medical Systems in a research report on Tuesday. Finally, Stifel Nicolaus cut their price objective on Inspire Medical Systems from $200.00 to $190.00 and set a "hold" rating on the stock in a report on Tuesday, January 21st. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $228.82.

Inspire Medical Systems Stock Performance

Shares of INSP traded down $2.42 during midday trading on Wednesday, hitting $184.73. 680,965 shares of the stock traded hands, compared to its average volume of 564,408. Inspire Medical Systems has a 1-year low of $123.00 and a 1-year high of $257.40. The firm has a market capitalization of $5.48 billion, a PE ratio of 172.65 and a beta of 1.32. The business's 50 day moving average price is $189.11 and its two-hundred day moving average price is $191.33.

Insider Activity at Inspire Medical Systems

In related news, CTO John Rondoni sold 583 shares of the business's stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total value of $99,395.67. Following the completion of the sale, the chief technology officer now owns 10,424 shares of the company's stock, valued at approximately $1,777,187.76. The trade was a 5.30 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 4.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Inspire Medical Systems

A number of large investors have recently added to or reduced their stakes in INSP. First Horizon Advisors Inc. boosted its position in Inspire Medical Systems by 885.7% during the fourth quarter. First Horizon Advisors Inc. now owns 138 shares of the company's stock worth $26,000 after purchasing an additional 124 shares during the period. True Wealth Design LLC bought a new stake in Inspire Medical Systems during the third quarter worth approximately $30,000. Farther Finance Advisors LLC boosted its position in Inspire Medical Systems by 1,158.3% during the third quarter. Farther Finance Advisors LLC now owns 151 shares of the company's stock worth $32,000 after purchasing an additional 139 shares during the period. Huntington National Bank boosted its position in Inspire Medical Systems by 228.3% during the fourth quarter. Huntington National Bank now owns 174 shares of the company's stock worth $32,000 after purchasing an additional 121 shares during the period. Finally, Harbour Investments Inc. boosted its position in Inspire Medical Systems by 101.0% during the fourth quarter. Harbour Investments Inc. now owns 197 shares of the company's stock worth $37,000 after purchasing an additional 99 shares during the period. Institutional investors own 94.91% of the company's stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.